Mixing vaccines — scientists call it “heterologous prime-boost” — is not a new idea, and researchers have experimented with it in fighting a handful of other diseases, including Ebola.
Russian researchers are testing a combination of their Sputnik V vaccine and the AstraZeneca shot. Sputnik is, itself, somewhat based on a mix-and-match approach, with the first and second shots having different formulations.